[
    "in vivo. Drug Metab Dispos. 2008; 36(6): 1 135- 42. </p> 30. Weber CC, Reising K, Miiller WE, Schubert-Zsilavecz M, and</p>Abdel-Tawab M. Modulation of Pgp function by boswellic acids. Planta Med. 2006; 72(6): 507-13. </p> 31. Kruger P, Kanzer J, Hummel J, Fricker G, Schubert- Zsilavecz M, Abdel-Tawab M. Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 \n\n and MRP2. Eur J Pharm Sci. 2009; 36 (2-3): 275-84. </p> 32. Sharma A, Gupta NK, Dixit VK. Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acid. Drug Deliv. 2010; 17(8): 587-95. </p> 33. Sterk V, Biichele B, Simmet T. Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Planta Med. 2004; 70(12): 1 155-60. </p> 34. Johnston M, Zakharov A, Armstrong D. Subarachnoid injection of Microfil reveals connections between cerebrospinal fluid and nasal lymphatics in the non-human primate. Neuropathol Appl Neurobiol. 2005; 31(6): 632-40. </p> 35. Ammon HP. Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine. 2010; 17(1 1): 862-7. </p> 36. Kumar A, Shah BA, Singh S, Hamid A, Singh SK, Sethi VK, Saxena AK, Singh J, Taneja SC. Acyl derivatives of boswellic acids as inhibitors of NF-kB and STATs. Bioorg Med Chem Lett. 2012; 22(1): 431- 5. </p> 37. Cao H, Yu R, Choi Y, Ma ZZ, Zhang H, Xiang W, Lee DYW, Berman BM, Moudgil KD, Fong HHS, and van Breemen RB. Discovery of cyclooxygenase inhibitors from medicinal plants used to treat inflammation. Phamacol Res. 2010; 61(6): 519-24. </p> 38. Siemoneit U, Koeberle A, Rossi A, Dehm F, Verhoff M, Reckel S, Majer TJ, Jauch J, Northoff H, Bernhard F, Doetsch V, Sautebin L and Werz O. Inhibition of microsomal prostaglandin E<sub>2</sub> synthase- 1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. British Journal of Pharmacology. 201 1 ; 162: 147-162. </p> 39. Tausch L, Henkel A, Siemoneit U, Poeckel D, Kather N, Franke L, Hofmann B, Schneider G, Angioni C, Geisslinger G, Skarke C, Holtmeier W, Beckhaus T, Karas M, Jauch J, Werz O. Identification of human cathepsin as a functional target of boswellic acids from the anti- \n\n inflammatory remedy frankincense. J Immunol. 2009; 183(5): 3433-42.</p>40. Roy S, Khanna S, Krishanaraju AV, Subbaraju GV, Yasmin T, Bagchi D, Sen CK. Regulation of vascular responses to inflammation: inducible matrix metalloproinase-3 expression in human microvascular endothelial cells is sensitive to antiinflammatory Boswellia. Antioxid Redox Signal. 2006; 8(3-4): 653-60. </p> 41. Henkel A, Kather N, Monch B, Northoff H, Jauch J, Werz O. Boswellic acids from frankincense inhibit lipopolysaccharide functionality through direct molecular interference. Biochem Pharmacol. 2012 83(1): 1 15-21. </p> 42. Saraswati S, Pandey M, Mathur R, Agrawal SS. Boswellic acid inhibits inflammatory angiogenesis "
]